drugset / Trial / NCT00840294

Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)

NCT00840294

Phase 3 Terminated 85 enrolled University of Chicago
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the impact of an empiric course of antibiotics for men with an elevated prostate-specific antigen (PSA) level.

Timeline

Start
2009-01
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 500 mg

Indications

No indication recorded.